A Phase II double-blind vehicle controlled crossover single dose (400 µG) V0147 gel effect and tolerance study in spinal cord injured patients with erectile dysfunction
A Phase II double-blind vehicle controlled crossover single dose (400 µG) V0147 gel effect and tolerance study in spinal cord injured patients with erectile dysfunction
A Phase II double-blind vehicle controlled crossover single dose (400 µG) V0147 gel effect and tolerance study in spinal cord injured patients with erectile dysfunction
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
40
Years old
Gender
Male
Therapeutic area :
Reproductive
Disease :
Erectile dysfunction
Study medication :
V0147
Phase :
Phase II
Start Date :
04 June 2007
End date :
25 July 2007
Study ID :
V00147 GL 202
EudraCT/CTIS number :
2007-001058-16
Send by email